ATCC ATCC Logo 0

Encephalitozoon intestinalis (Cali et al.) Hartskeerl et al.

50651

Product category
Protists
Product type
Parasitic protozoan
Classification
Opisthokonta, Fungi, Microsporidia
Strain designation
CDC:V297
Type strain
No
Isolation source
Man with AIDS (clinical isolate)
Geographical isolation
United States; California
Applications
Agricultural research
Enteric disease research
Infectious disease research
Product format
Frozen
Storage conditions
-80°C or colder for 1 week, vapor phase of liquid nitrogen for long-term storage
Buy Now
Price: $376.00 EA
Discounts are available for our fellow nonprofit organizations.

Generally ships within 1-3 business days

Documentation

Haven't found what you need?

Customize solution

We tailor our materials for your specific application.

Get application-specific materials

Biosafety Icon BSL 2

ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. It is your responsibility to understand the hazards associated with the material per your organization’s policies and procedures as well as any other applicable regulations as enforced by your local or national agencies.

ATCC highly recommends that appropriate personal protective equipment is always used when handling vials. For cultures that require storage in liquid nitrogen, it is important to note that some vials may leak when submersed in liquid nitrogen and will slowly fill with liquid nitrogen. Upon thawing, the conversion of the liquid nitrogen back to its gas phase may result in the vial exploding or blowing off its cap with dangerous force creating flying debris. Unless necessary, ATCC recommends that these cultures be stored in the vapor phase of liquid nitrogen rather than submersed in liquid nitrogen.

Required Products

These products are vital for the proper use of this item and have been confirmed as effective in supporting functionality. If you use alternative products, the quality and effectiveness of the item may be affected.

BS-C-1

CCL-26

Price: $495.00 ea

Eagle's Minimum Essential Medium (EMEM)

30-2003

Price: $21.00 ea

Fetal Bovine Serum (FBS)

30-2020

Price: $645.00 ea

Detailed product information

General

Specific applications
Enteric Research
Food and waterborne pathogen research
Opportunistic pathogen research

Characteristics

Comments
flow cytometric analysis
detection of drug-induced effects in infected green monkey kidney cells
Western blot and immunofluorescence analysis
Control strain for enterocytozoan identification
characterization

Handling information

Host
Instruction for complete medium
ATCC® 30-2003 [Eagle's Minimum Essential Medium (EMEM) with 2 mM L-glutamine and Earle's BSS adjusted to contain 1.5 g/L sodium bicarbonate, 0.1 mM non-essential amino acids, and 1.0 mM sodium pyruvate]
Temperature
35°C
Handling procedure
Cell Line Maintenance

  1. To establish a cell culture from the frozen state place an ampule in a water bath set at 35°C (2-3 min). Immerse the vial just sufficient to cover the frozen material. Do not agitate the vial.
  2. Immediately after thawing, aseptically remove the contents of the ampule and inoculate into 10.0 mL of fresh ATCC® 30-2003 with 10% (v/v) Heat-Inactivated Fetal Bovine Serum (HIFBS)* in a T-25 tissue culture flask.
  3. Outgas the flask for 10 seconds with a 95% air, 5% CO2 gas mixture.
  4. Incubate in a 35°C CO2 incubator with the caps screwed on tightly.
  5. Change the medium 1-2 times per week.  
    *Fetal bovine serum is available from ATCC (catalog number 30-2020). Serum is heat-inactivated by exposure to 56°C for 30 minutes. This treatment will inactivate proteins of the complement pathway. Remove the serum from the refrigerator and aseptically distribute in 100 mL aliquots to sterile 125 mL screw-capped bottles. Immerse bottles in a 35°C water bath for 5 minutes. Do not directly transfer bottles from the refrigerator to 56°C. Transfer the bottles to a 56°C water bath and begin timing for 30 minutes. To avoid contamination, do not allow the level of the water in the bath to come in contact with the lip of the screw cap. It is best to leave one inch between the serum level in the bottle and the lip of the cap and to fill the water bath to a level just slightly above the level of the serum. To assure even heating of the serum, swirl the bottle(s) every ten minutes.

 

Transferring the Cell Line

  1. When the cell line forms a confluent layer, remove all the medium and replace it with 2 mL of 0.25% (w/v) trypsin dissolved in Hank's Balanced Salt Solution.
  2. Gently distribute the trypsin over the monolayer, remove the trypsin, and place the flask at 35°C for 10 min.
  3. Add 2 mL of ATCC® 30-2003 with 10% (v/v) HIFBS and detach any cells still adherent by alternately aspirating the medium into a pipette and discharging the contents over the monolayer.
  4. Distribute the cell suspension in 0.5 mL aliquots to 4 T-25 flasks containing 10 mL fresh ATCC® 30-2003 with 10% (v/v) HIFBS.
  5. Outgas the flask for 10 seconds with a 95% air, 5% CO2 gas mixture.
  6. Incubate in a 35°C CO2 incubator with the caps screwed on tightly.

 

Storage and Culture Initiation
Frozen ampules packed in dry ice should either be thawed immediately or stored in liquid nitrogen.  If liquid nitrogen storage facilities are not available, frozen ampoules may be stored at or below -70°C for approximately one week.  Do not under any circumstance store frozen ampules at refrigerator freezer temperatures (generally -20°C).  Storage of frozen material at this temperature will result in the death of the culture.
  1. To thaw a frozen ampule, place it in a 35°C water bath such that the lip of the ampule remains above the water line. Thawing time is approximately 2 to 3 minutes.  Do not agitate the ampule.  Do not leave ampule in water bath after it is thawed.
  2. Immediately after thawing, aseptically transfer contents to a T-25 tissue culture flask containing a fresh monolayer of ATCC® CCL-26™ cells and 10 mL ATCC® 30-2003 with 3% (v/v) HIFBS.
  3. Outgas the flask for 10 seconds with a 95% air, 5% CO2 gas mixture.
  4. Incubate in a 35°C CO2 incubator with the caps screwed on tightly.
Culture maintenance
  1. Remove the medium from a fresh confluent monolayer of CCL-26™ cells in a T-25 tissue culture flask and replace it with 10 mL of ATCC® 30-2003 with 3% (v/v) HIFBS.
  2. To transfer the culture, remove the old medium containing the organism and centrifuge at 1300 x g for 10 min.
  3. Remove the supernatant and resuspend the cell pellet.  Transfer the resuspended pellet to the fresh flask of CCL-26™ cells.
  4. Outgas the flask for 10 seconds with a 95% air, 5% CO2 gas mixture.
  5. Incubate in a 35°C CO2 incubator with the caps screwed on tightly.
Cryopreservation
  1. Harvest the culture by gently agitating the contents of each flask.  Transfer all but approximately 1 mL of the culture medium to 15 mL plastic centrifuge tubes. Detach the remaining tissue culture cells (infected and uninfected) by scraping the surface of the flask with a cell scraper. Pass the resulting cell suspension through a syringe equipped with a 27 gauge 1/2 in needle and pool this suspension with the culture fluid.
  2. Spin the cell suspensions at approximately 50 x g for 3 min, to remove the cellular debris.
  3. Transfer the spore suspensions (supernatants) to new 15 mL plastic centrifuge tubes.  Centrifuge at 1300 x g for 10 min.
  4. Pool the spore pellets and adjust the concentration to 2.0 - 4.0 x 107 cells/mL with a fresh solution of Hank's Balanced Salt Solution.
    *If the concentration is too low centrifuge at 1300 x g for 10 min and resuspend in the volume of Hank's Balanced Salt Solution required to yield the desired concentration.
  5. Mix the spore preparation and 20% (v/v) DMSO in equal portions.  The final concentration will be 1.0 - 2.0 x 107 cells/mL and 10% DMSO.  The time from the mixing of the cell preparation and the cryoprotective solution before the freezing process begins should be no less than 15 min. and no more than 30 min.
  6. Dispense in 0.5 mL aliquots to 1.0-2.0 mL sterile plastic screw-capped cryules (special plastic vials for cryopreservation).
  7. Place the vials in a controlled rate freezing unit.  From room temperature cool at -1°C/min to -40°C.  If the freezing unit can compensate for the heat of fusion, maintain rate at -1°C/min through the heat of fusion.  At -40°C plunge into liquid nitrogen. Alternatively, place the vials in a Nalgene 1°C freezing apparatus.  Place the apparatus at -80°C for 1.5 to 2 hours and then plunge ampules into liquid nitrogen.  (The cooling rate in this apparatus is approximately -1°C/min.)  
  8. Store in either the vapor or liquid phase of a nitrogen refrigerator.
  9. To thaw a frozen ampule, place it in a 35°C water bath such that the lip of the ampule remains above the water line. Thawing time is approximately 2 to 3 minutes.  Do not agitate the ampule.  Do not leave ampule in water bath after thawed.
  10. Immediately after thawing, aseptically transfer contents to a T-25 tissue culture flask containing a fresh monolayer of ATCC® CCL-26™ cells and 10 mL ATCC® 30-2003 with 3% (v/v) HIFBS.
  11. Outgas the flask for 10 seconds with a 95% air, 5% CO2 gas mixture.
  12. Incubate in a 35°C CO2 incubator with the caps screwed on tightly.

History

Deposited as
Encephalitozoon intestinalis (Cali et al.) Hartskeerl et al.
Depositors
GS Visvesvara
Type of isolate
Human
Year of origin
1993
Patient age
26 years
Patient gender
Male
Special collection
NCRR Contract

Legal disclaimers

Intended use
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
Warranty

The product is provided 'AS IS' and the viability of ATCC® products is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product information sheet, website, and Certificate of Analysis. For living cultures, ATCC lists the media formulation and reagents that have been found to be effective for the product. While other unspecified media and reagents may also produce satisfactory results, a change in the ATCC and/or depositor-recommended protocols may affect the recovery, growth, and/or function of the product. If an alternative medium formulation or reagent is used, the ATCC warranty for viability is no longer valid.  Except as expressly set forth herein, no other warranties of any kind are provided, express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a particular purpose, manufacture according to cGMP standards, typicality, safety, accuracy, and/or noninfringement.

Disclaimers

This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.

While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.

This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the ATCC product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided 'AS IS' with no representations or warranties whatsoever except as expressly set forth herein and in no event shall ATCC, its parents, subsidiaries, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer's use of the product. While reasonable effort is made to ensure authenticity and reliability of materials on deposit, ATCC is not liable for damages arising from the misidentification or misrepresentation of such materials.

Please see the material transfer agreement (MTA) for further details regarding the use of this product. The MTA is available at www.atcc.org.

Permits & Restrictions

Import Permit for the State of Hawaii

If shipping to the U.S. state of Hawaii, you must provide either an import permit or documentation stating that an import permit is not required. We cannot ship this item until we receive this documentation. Contact the Hawaii Department of Agriculture (HDOA), Plant Industry Division, Plant Quarantine Branch to determine if an import permit is required.

MORE INFORMATION ABOUT PERMITS AND RESTRICTIONS

References

Curated Citations

Gatti S, et al. Extraintestinal microsporidiosis in AIDS patients: clinical features and advanced protocols for diagnosis and characterization of the isolates. J. Eukaryot. Microbiol. 44: 79S, 1997. PubMed: 9508459

Croppo GP, et al. Western blot and immunofluorescence analysis of a human isolate of Encephalitozoon cuniculi established in culture from the urine of a patient with AIDS. J. Parasitol. 83: 66-69, 1997. PubMed: 9057698

Moss DM, et al. Flow cytometric analysis of microsporidia belonging to the genus Encephalitozoon. J. Clin. Microbiol. 37: 371-375, 1999. PubMed: 9889221

Moura H, et al. Detection by an immunofluorescence test of Encephalitozoon intestinalis spores in routinely formalin-fixed stool samples stored at room temperature. J. Clin. Microbiol. 37: 2317-2322, 1999. PubMed: 10364604

del Aguila C, et al. Identification of Enterocytozoon bieneusi spores in respiratory samples from an AIDS patient with a 2-year history of intestinal microsporidiosis. J. Clin. Microbiol. 35: 1862-1866, 1997. PubMed: 9196210

View All Curated Citations for this Product

Frequently Asked Questions

Need assistance with this product? Contact our Technical Support team.

Telephone

Telephone

US and Puerto Rico

800-638-6597

Outside the US

+1-703-365-2700
hours

Hours of Operation

Monday-Friday
9:30am - 5:30pm
US Eastern Time